Evidence mapPaperPMID 41897259Full record

ReviewHealthcare (Basel, Switzerland)2026

Artificial Intelligence for Early Detection and Prediction of Chronic Obstructive Pulmonary Disease Exacerbations.

LeAnn Boyce, Victor Prybutok

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

LeAnn BoyceDepartment of Analytics and Statistics, College of Science, University of North Texas, Denton, TX 76203, USA.ORCID 0000-0002-9638-6088
Victor PrybutokDepartment of Information Technology and Decision Sciences, G. Brint Ryan College of Business, University of North Texas, Denton, TX 76203, USA.ORCID 0000-0003-3810-9039

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExacerbations of chronic obstructive pulmonary disease (COPD) are a leading cause of morbidity, mortality, and healthcare burden worldwide. Early detection and timely intervention remain important challenges in COPD management, given the unpredictable nature of acute deterioration and limitations of traditional spirometry-based risk assessment.

methodsThis narrative review synthesizes artificial intelligence (AI)-driven approaches for predicting and detecting chronic obstructive pulmonary disease (COPD) exacerbations across electronic health records, wearable sensors, imaging, environmental data, and patient-reported outcomes, emphasizing novel discoveries and emerging relationships rather than predictive performance.

resultsThree major discoveries have been made. First, measurable physiological and behavioral deterioration may precede symptom recognition by approximately 7-14 days, thereby establishing a potential intervention window for anticipatory care. Second, machine learning (ML) models integrating pollutant exposure, medication adherence, and clinical characteristics have identified phenotypes with differential environmental sensitivity, including unexpected exposure-adherence interactions. Third, deep neural network analysis of full spirometry curves has revealed structural phenotypes beyond traditional Forced Expiratory Volume (FEV

conclusionsAI has uncovered hidden patterns in the progression of COPD, supporting a shift from reactive to anticipatory management. Translation to routine care requires prospective validation, improved interpretability, workflow integration, and generalizability and equity.

Indexed as

artificial intelligencechronic obstructive pulmonary disease (COPD)clinical decision supportCOPD exacerbationdeep learningelectronic health recordsexplainable artificial intelligencemachine learningprecision medicinewearable sensors

Identifiers

PMID41897259
PMCPMC13026585

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.